March 6th 2021, 4:00pm
By Ryan McDonald
A roundup of some of the latest news and updates for patients with breast cancer from CURE®
March 6th 2021, 2:06am
By Darlene Dobkowski, MA
This accelerated FDA approval is the first CAR T-cell therapy approved for the treatment of patients with indolent follicular lymphoma.
March 5th 2021, 9:00pm
By Brielle Benyon
Last week, the Food and Drug Administration (FDA) was scheduled to make a decision on whether or not they would approve oral paclitaxel plus encequidar for the treatment of metastatic breast cancer. The agency decided not to approve the regimen, and issued a complete response letter outlining why.
March 5th 2021, 7:00pm
Merck – the manufacturer of Keytruda (pembrolizumab) – is pulling the immunotherapy drug’s indication for patients with metastatic small cell lung cancer whose disease progressed on or after platinum-based chemotherapy and one or more prior line of therapy.
March 5th 2021, 5:00pm
By William Ramshaw
A pancreatic cancer survivor shares why he writes about his journey and encourages other patients and survivors to do the same.
March 5th 2021, 4:00pm
By Jessica Skarzynski
From President Biden convening a bipartisan meeting to discuss cancer treatments and research to a 5-year-old patient with hepatoblastoma asking for donations to a local food bank instead of presents for her birthday, here’s what’s happening in the cancer space this week.
March 5th 2021, 2:00pm
The International Association for the Study of Lung Cancer recently joined more than 100 cancer centers and organizations in urging leading public health officials to prioritize administering the COVID-19 vaccine to cancer survivors and patients undergoing treatment for the disease.
March 4th 2021, 10:00pm
While it is important to educate oneself after receiving a diagnosis of cancer, it’s also critical to know when to step away and find a balance between cancer and life, according to Diane Zipursky-Quale.
March 4th 2021, 7:00pm
By Antonia DePace
Having an exercise professional in chemotherapy infusion suites could significantly benefit patients with cancer and help improve health-related outcomes such as fatigue, according to recent study results.
March 4th 2021, 5:00pm
By Julie S. Brokaw
An ovarian cancer survivor shares that although she’s been frustrated and mad about a recent recurrence in her lymph nodes, she still celebrates the life that she’s been blessed with.
March 4th 2021, 4:00pm
This week on the “CURE® Talks Cancer” podcast, to kick off Colorectal Cancer Awareness Month, we spoke with colon cancer survivor April Schack about what it was like to be diagnosed at age 36 and how she’s working with Fight CRC on a new campaign that aims to raise awareness about the disease, so that no one has to go through what she did.
March 4th 2021, 2:00pm
Women with a history of depression had higher rates of cancer-related fatigue, according to recent study results.
March 4th 2021, 2:08am
This approval expands a previous accelerated approval of the drug in 2018, allowing it for use in patients with brain metastases.
March 3rd 2021, 10:00pm
By Kristie L. Kahl
CURE spoke with Dr. Ogori Kalu, on behalf of the Triple-Negative Breast Cancer Foundation, about the psychosocial effects from a diagnosis, as well as treatment and its side effects.
March 3rd 2021, 7:00pm
Patients treated with Imbruvica plus TG-1101 had an overall response rate of 83% compared with 65% in those treated with Imbruvica alone.
Why It’s Important to ‘Live Well With Your Cancer’
‘No Excuses’ When It Comes to Colorectal Cancer Awareness
Understanding Triple-Negative Breast Cancer
CRC POP: Arming Newly Diagnosed CRC Patients With Useful Resources
